[go: up one dir, main page]

WO2004022542A3 - Substituierte 1,2,3,4-tetrahydrochinolinderivate - Google Patents

Substituierte 1,2,3,4-tetrahydrochinolinderivate Download PDF

Info

Publication number
WO2004022542A3
WO2004022542A3 PCT/EP2003/008889 EP0308889W WO2004022542A3 WO 2004022542 A3 WO2004022542 A3 WO 2004022542A3 EP 0308889 W EP0308889 W EP 0308889W WO 2004022542 A3 WO2004022542 A3 WO 2004022542A3
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
tetrahydroquinoline derivatives
tetrahydroquinoline
derivatives
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/008889
Other languages
English (en)
French (fr)
Other versions
WO2004022542A2 (de
Inventor
Hagen-Heinrich Hennies
Corinna Sundermann
Michael Przewosny
Bernd Sundermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Priority to AU2003258598A priority Critical patent/AU2003258598A1/en
Publication of WO2004022542A2 publication Critical patent/WO2004022542A2/de
Publication of WO2004022542A3 publication Critical patent/WO2004022542A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die vorliegende Erfindung betrifft substituierte ,1,2,3,4-Tetrahydrochinolinderivate, sowie Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von Arzneimitteln und Arzneimittel enthaltend diese Verbindungen.
PCT/EP2003/008889 2002-08-12 2003-08-11 Substituierte 1,2,3,4-tetrahydrochinolinderivate Ceased WO2004022542A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003258598A AU2003258598A1 (en) 2002-08-12 2003-08-11 Substituted 1,2,3,4-tetrahydroquinoline derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10236910.0 2002-08-12
DE2002136910 DE10236910A1 (de) 2002-08-12 2002-08-12 Substituierte 1,2,3,4-Tetrahydrochinolinderivate

Publications (2)

Publication Number Publication Date
WO2004022542A2 WO2004022542A2 (de) 2004-03-18
WO2004022542A3 true WO2004022542A3 (de) 2004-06-03

Family

ID=31501737

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/008889 Ceased WO2004022542A2 (de) 2002-08-12 2003-08-11 Substituierte 1,2,3,4-tetrahydrochinolinderivate

Country Status (3)

Country Link
AU (1) AU2003258598A1 (de)
DE (1) DE10236910A1 (de)
WO (1) WO2004022542A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10360154A1 (de) * 2003-12-20 2005-07-21 Merck Patent Gmbh Tetrahydrochinoline
PT2033959E (pt) * 2003-12-20 2011-07-29 Merck Patent Gmbh Derivados de tetra-hidropiranoquinolina
DE102004020908A1 (de) 2004-04-28 2005-11-17 Grünenthal GmbH Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
DE102005027169A1 (de) * 2005-06-13 2006-12-14 Merck Patent Gmbh Tetrahydrochinolinderivate
WO2008109007A1 (en) * 2007-03-02 2008-09-12 Cara Therapeutics, Inc. Bridged phenanthridines
US8546427B2 (en) * 2010-10-20 2013-10-01 Hoffmann-La Roche Inc. Tetrahydroquinoline derivatives
ES2749512T3 (es) * 2012-10-02 2020-03-20 Inst Nat Sante Rech Med Derivados de tetrahidroquinolina y su uso como inhibidores de Epac
CN110372589B (zh) * 2019-08-13 2020-12-25 聊城大学 4-(4-叔丁基苯基)-2-苯基-1,2,3,4-四氢喹啉-8-甲酸甲酯的制法
CA3201443A1 (en) 2020-12-25 2022-06-30 Toray Industries, Inc. Tetrahydroquinoline derivative and medicinal use thereof
JPWO2023249106A1 (de) 2022-06-24 2023-12-28

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017584A (en) * 1984-12-20 1991-05-21 Sterling Drug Inc. Antidepressant 2-(4,5-dihydro-1H-imidazolyl)-dihydro-1H-indoles, -1,2,3,4-tetrahydroquinolines and -1H-indoles, and methods of use thereas
US5461063A (en) * 1992-08-10 1995-10-24 Merck Sharp & Dohme Limited Azabicyclic compounds
WO1998027093A1 (en) * 1996-12-18 1998-06-25 Eli Lilly And Company Combinatorial process for preparing hydrofuroquinoline libraries
WO1998034111A1 (en) * 1997-02-04 1998-08-06 Trega Biosciences, Inc. Tricyclic tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries
WO1998034115A1 (en) * 1997-02-04 1998-08-06 Trega Biosciences, Inc. 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries
WO2001058875A2 (de) * 2000-02-07 2001-08-16 Grünenthal GmbH Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
WO2003015715A2 (en) * 2001-08-20 2003-02-27 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives as antithrombotic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
DE69622731T2 (de) * 1995-09-29 2003-02-20 Glaxosmithkline S.P.A., Verona Tetrahydrochinoline als nmda antagonisten

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017584A (en) * 1984-12-20 1991-05-21 Sterling Drug Inc. Antidepressant 2-(4,5-dihydro-1H-imidazolyl)-dihydro-1H-indoles, -1,2,3,4-tetrahydroquinolines and -1H-indoles, and methods of use thereas
US5461063A (en) * 1992-08-10 1995-10-24 Merck Sharp & Dohme Limited Azabicyclic compounds
WO1998027093A1 (en) * 1996-12-18 1998-06-25 Eli Lilly And Company Combinatorial process for preparing hydrofuroquinoline libraries
WO1998034111A1 (en) * 1997-02-04 1998-08-06 Trega Biosciences, Inc. Tricyclic tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries
WO1998034115A1 (en) * 1997-02-04 1998-08-06 Trega Biosciences, Inc. 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries
WO2001058875A2 (de) * 2000-02-07 2001-08-16 Grünenthal GmbH Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
WO2003015715A2 (en) * 2001-08-20 2003-02-27 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives as antithrombotic agents

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HOEMANN, MICHAEL Z. ET AL: "Potent In vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002), 12(2), 129-132, XP002265033 *
KOBAYASHI S ET AL: "A CONVENIENT METHOD FOR LIBRARY CONSTRUCTION: PARALLEL SYNTHESIS OF BETA-AMINO ESTER AND QUINOLINE DERIVATIVES IN LIQUID PHASE USING LN(OTF)3-CATALYZED THREE-COMPONENT REACTIONS", BIOTECHNOLOGY AND BIOENGINEERING - COMBINATORIAL CHEMISTRY, WILEY, NEW YORK, NY, US, vol. 61, no. 1, 1998, pages 23 - 31, XP002145305, ISSN: 0006-3592 *
KOBAYASHI S ET AL: "LANTHANIDE TRIFLATE CATALYZED IMINO DIELS-ALDER REACTIONS;CONVENIENT SYNTHESES OF PYRIDINE AND QUINOLINE DERIVATIVES", SYNTHESIS, GEORG THIEME VERLAG. STUTTGART, DE, vol. 9, September 1995 (1995-09-01), pages 1195 - 1202, XP002941298, ISSN: 0039-7881 *
LEARDINI, R.; ET AL., J. ORG. CHEM., vol. 57, 1992, pages 1842 - 1848, XP002274144 *

Also Published As

Publication number Publication date
AU2003258598A1 (en) 2004-03-29
WO2004022542A2 (de) 2004-03-18
DE10236910A1 (de) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
AU2002219173A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2003257465A1 (en) Substituted diaryl heterocycles, method for the production and use thereof as medicaments
AU2002231688A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
MXPA03005018A (es) Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos, y su uso.
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
AU2001284021A1 (en) Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
WO2002030870A3 (de) Substituierte c-cyclohexylmethylamin-derivate
ZA200506422B (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
WO2001049654A3 (de) Substituierte aminomethyl-phenyl-cyclohexanderivate
WO2001058875A3 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
WO2004022542A3 (de) Substituierte 1,2,3,4-tetrahydrochinolinderivate
WO2001049651A3 (de) Aminomethyl-phenyl-cyclohexanonderivate
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA03006648A (es) Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP